SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Repayments of Convertible Debt
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Repayments of Convertible Debt of $846.81 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2026-03-31
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. repayments of convertible debt for the quarter ending 2024-12-31 was $0.00.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. repayments of convertible debt for the quarter ending 2024-09-30 was $345.14K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. repayments of convertible debt for fiscal 2024 was $846.81K, a 153.20% increase from fiscal 2023.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. repayments of convertible debt for fiscal 2023 was $334.44K.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $345.14K derived: sum of 2 quarters · filed 2026-03-31 | $846.81K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $345.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $846.81K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $501.67K 10-Q · filed 2025-08-13 | |||
| 2023-12-31 | $334.44K 10-K/A · filed 2024-09-04 | |||
| 2022-09-30 | $50.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |